Children with psoriasis and COVID‐19: factors associated with an unfavourable COVID‐19 course, and the impact of infection on disease progression (Chi‐PsoCov registry)

202214 citationsJournal Articlegreen Open Access

Authors

Jinane Zitouni · Centre Hospitalier Victor Dupouy

A.‐C. Bursztejn · Centre Hospitalier Régional et Universitaire de Nancy

Anna Belloni Fortina · University of Padua

Alain Beauchet · Hôpital Ambroise-Paré

Vito Di Lernia · Azienda Sanitaria Unità Locale di Reggio Emilia

Aleksandra Lesiak · Medical University of Lodz

Jason Thomas

Abstract

Biologics appear to be safe with no increased risk of severe form of COVID-19 in children with psoriasis. COVID-19 was responsible for the development of psoriasis or the worsening of a known psoriasis for some children.

Topics & Keywords

Psoriasis: Treatment and Pathogenesis Autoimmune and Inflammatory Disorders Research Dermatological and COVID-19 studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of the European Academy of Dermatology and Venereology

Volume 36, Issue 11, pp. 2076-2086

DOI: 10.1111/jdv.18361

Field-Weighted Citation Impact: 1.19